Investigational drug · Phase 2
SCTV04C
Also called: Recombinant Herpes Zoster Vaccine -Dose
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Herpes Zoster.
Phase 2Last checked: Nov 19, 2026Latest source record: Jan 30, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "SCTV04C"
First trial start
2025
Feb 15, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "SCTV04C", any sponsor or status.
Conditions studied
As listed on its trial records.
- Herpes Zoster
Approved drugs for the same conditions: Herpes and shingles · Infectious disease and vaccines
Largest trials
Live from ClinicalTrials.gov: studies naming "SCTV04C" as an intervention, largest first.
- A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster VaccinePivotal-lookingNot yet recruiting
Sinocelltech Ltd.Industry
NCT06801509 · 540 participants (planned) · Start Feb 15, 2025 · Primary completion Nov 10, 2025
Drug: Recombinant Herpes Zoster Vaccine (SCTV04C) Low-Dose; Recombinant Herpes Zoster Vaccine (SCTV04C) High-Dose and 3 more · For: Herpes Zoster
Sites: Dazhou, China
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Herpes Zoster
- CHO Cellrecombinant zoster vaccine, Recombinant Respiratory Syncytial Virus VaccinePhase 39 trials
MAXVAX Biotechnology Limited Liability Company · Herpes Zoster, Respiratory Syncytial Virus (RSV), Herpes Zoster (HZ)
- Active Comparator vaccinePhase 36 trials
Sinovac Biotech Co., Ltd · Epidemic Meningitis, Meningococcal Vaccines, Herpes Zoster
- su vaccineRZVPhase 32 trials
GSK · Herpes Zoster, Respiratory Syncytial Virus (RSV)
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.